# NALOXONE HYDROCHLORIDE
> **ANDA214792** · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2022-11-07
## Drug
- **FDA Application Number:** ANDA214792
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NALOXONE HYDROCHLORIDE
- **Generic name:** NALOXONE HYDROCHLORIDE
- **Active ingredients:** NALOXONE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2022-11-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214792)
---
*AI Analytics · CC0 1.0*